Skip to content
Screener

Ultragenyx Pharmaceutical RARE Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$37.91+86.7%
Amgen logo
AmgenAMGN
$21.49+56.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.66-23.3%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.31-15.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.55+70.5%
Regenxbio logo
RegenxbioRGNX
$1.35-67.4%

Other financials

Income statement

See full
Revenue$214.0M+28.1%
Operating income-$75.0M+30.6%
Net income-$92.0M+20.0%
EPS (diluted)-$0.90+23.1%

Balance sheet

See full
Cash & equivalents$125.0M-29.0%
Total debt$36.0M-10.8%
Total equity-$291.0M-293%
Total assets$1.3B-3.2%

Cash flow

See full
Operating cash flow-$97.0M+11.0%
CapEx$1.0M-66.7%
Free cash flow-$98.0M+12.5%

Valuation

See full
Market cap$2.55B-5.8%
P/S3.6×-0.9×

Profitability

See full
Gross margin97.2%
Operating margin-73.6%-7.3pp
Net margin-81.7%-4.9pp
FCF margin-68.2%-1.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×
Current ratio1.7×-0.7×

Where this comes from

Calculated from Ultragenyx Pharmaceutical’s reported figures.

Based on the most recent quarter.

The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333233

FAQ

What is Ultragenyx Pharmaceutical's book value per share?
Ultragenyx Pharmaceutical (RARE) reported book value per share of -$2.86 in Q2 2026.
How has Ultragenyx Pharmaceutical's book value per share changed year-over-year?
Ultragenyx Pharmaceutical's book value per share decreased by 286.3% year-over-year, from $1.53 to -$2.86.
What is the long-term trend for Ultragenyx Pharmaceutical's book value per share?
Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's book value per share has grown at a -46.8% compound annual growth rate (CAGR), from $18.97 to -$0.81.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Ultragenyx Pharmaceutical's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude